PuSH - Publication Server of Helmholtz Zentrum München: Inborn error of immunity or atopic dermatitis: When to be concerned and how to investigate.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Stadler, P.C.* ; Renner, E.D. ; Milner, J.* ; Wollenberg, A.*

Inborn error of immunity or atopic dermatitis: When to be concerned and how to investigate.

J. Allergy Clin. Immunol. 9, 1501-1507 (2021)

DOI

PMC

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Around 20% of all children worldwide suffer from Atopic Dermatitis (AD). Therefore, eczematous skin lesions and elevated serum Immunglobulin E (IgE) levels are common findings. Inborn Errors of Immunity (IEI) may be missed in the context of AD, and management and prognosis of these conditions can be substantially different. Children suffering from IEIs such as Hyper-IgE-Syndromes (HIES), Wiskott-Aldrich-syndrome (WAS), Immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, Omenn syndrome, the atypical complete DiGeorge syndrome and skin barrier disorders like Comèl-Netherton-syndrome and Severe-dermatitis-multiple-allergies-and-metabolic-wasting (SAM) syndrome may present with additional "red flags", which should raise a clinical suspicion for an underlying IEI. These "red flags" may include eczematous skin lesion manifesting prior to two month of life, disseminated or recurrent viral, bacterial or fungal infections, mucocutaneous candidiasis, purpura, chronic diarrhea, or abnormalities in development or of connective tissue. A differential blood count, as well as a lymphocyte subset analysis, total immunoglobulin levels and vaccination titers can help the clinician to decide whether a patient with eczematous skin lesions and elevated serum IgE should be referred to a clinical immunologist for a full immunologic work-up and broad genetic analysis.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

10.793

0.000